{"id":331,"date":"2026-09-10T16:00:36","date_gmt":"2026-09-10T16:00:36","guid":{"rendered":"https:\/\/www.coveragefox.com\/knowledge-center\/?p=331"},"modified":"2026-09-10T16:06:42","modified_gmt":"2026-09-10T16:06:42","slug":"are-glp-1-medications-covered-by-insurance","status":"publish","type":"post","link":"https:\/\/www.coveragefox.com\/knowledge-center\/are-glp-1-medications-covered-by-insurance\/","title":{"rendered":"Are GLP-1 Medications Covered by Insurance?"},"content":{"rendered":"\n<div class=\"c-section c-section--not-top-padding  \" >\n    <div class=\"o-wrapper o-wrapper--small\">\n        <div class=\"c-section__content\">\n\n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_779543dd6711ecdea4d5f2820f245eb3\">\n                                      <p>If you take or are considering a GLP-1 medication like Ozempic, Wegovy, Mounjaro, or Zepbound, one of the first questions you&#8217;ll face is whether your <a href=\"https:\/\/www.coveragefox.com\/health-insurance-plans\/\">health insurance<\/a> will actually help pay for it. Coverage depends on your diagnosis, your insurance plan, and your state\u2019s policies. This guide explains how insurance coverage for GLP-1 medications works and offers tips to improve your chances of approval.<\/p>\n<h3>Key Takeaways<\/h3>\n                   <\/div>\n\n\n\n<ul class=\"c-list-check\">\n                        <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Coverage for GLP-1 medications varies depending on whether they\u2019re prescribed for type 2 diabetes, weight loss, or major cardiovascular events. Each insurer sets its own formulary rules, so coverage can differ even between plans from the same company.<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Private and government plans are more likely to cover GLP-1 drugs for diabetes and cardiovascular risk reduction than for obesity or weight loss alone.<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Medicaid coverage for GLP-1s used to treat obesity varies widely by state. As of January 2026, only 13 states cover these drugs for obesity in fee-for-service programs, while four states have dropped coverage due to budget constraints.<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>High costs of GLP-1 medications contribute to insurers tightening prior authorization rules and increasing cost-sharing, especially for weight loss.<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Many privately insured adults seeking to lose weight face challenges obtaining coverage, as many employer-sponsored plans exclude weight loss drugs or require extensive documentation.<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Serious side effects like severe stomach problems and allergic reactions are important to discuss with your healthcare professional before starting treatment.<\/p>\n            <\/div>\n        <\/li>\n\n        \n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_db4d8a606ff62b4d06ad2bea93400180\">\n                            <h2 >What Are GLP-1 Medications and Why Are They So Popular?<\/h2>                                      <p>GLP-1 receptor agonists are prescription medicines originally developed for type 2 diabetes. They mimic the GLP-1 hormone, which regulates blood sugar, slows stomach emptying, and reduces appetite, aiding weight loss.<\/p>\n<p>Popular brands include Novo Nordisk\u2019s semaglutide (Ozempic for diabetes, Wegovy for weight management) and Eli Lilly\u2019s tirzepatide (Mounjaro for diabetes, Zepbound for weight loss). Wegovy also helps reduce cardiovascular events in adults with obesity and heart disease.<\/p>\n<p>These drugs carry risks, including nausea, vomiting, diarrhea, and rare, serious effects like severe stomach or kidney problems. Always consult your doctor before starting. GLP-1 ads have become common, reflecting their mainstream use but also the need to heed safety warnings.<\/p>\n                   <\/div>\n\n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_57e6859f84f928c5b362d66fd039048b\">\n                            <h2 >Are GLP-1s Covered by Private Health Insurance for Weight Loss and Diabetes?<\/h2>                                      <p>Whether a private plan covers GLP-1 medications depends almost entirely on the specific plan and the diagnosis. Most private insurance plans cover GLP-1 medications for Type 2 diabetes, typically placing them on higher formulary tiers with prior authorization and step therapy requirements. Coverage is more likely for FDA-approved uses than for weight loss alone.<\/p>\n<p>For <a href=\"https:\/\/www.coveragefox.com\/knowledge-center\/aca-vs-private-health-insurance-whats-the-difference\/\">privately insured<\/a> adults seeking a weight loss drug, the picture is much less favorable. Many employer-sponsored plans exclude coverage for weight loss medications entirely. When obesity coverage exists, insurers typically require:<\/p>\n                   <\/div>\n\n\n\n<ul class=\"c-list-check\">\n                        <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>A BMI of 30 or higher (or 27+ with other conditions like hypertension or sleep apnea).<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Documentation of failed lifestyle interventions, including a reduced calorie diet and exercise.<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Ongoing proof of weight loss and adherence to qualify for continued coverage.<\/p>\n            <\/div>\n        <\/li>\n\n        \n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_ec11f5d83451ec8b4b7cb37fdfcf1589\">\n                                      <p>Some plans also mandate step therapy, trying older, cheaper drugs first. Independent Health, for example, requires a BMI of 40 or above plus at least two obesity-related comorbidities for prior authorization.<\/p>\n<p>Cost sharing adds another layer. Even when a plan covers the drug, copays or coinsurance on a $1,000+ monthly medication can run anywhere from $25 to several hundred dollars, depending on your tier, <a href=\"https:\/\/www.coveragefox.com\/knowledge-center\/how-health-coverage-premiums-and-deductibles-work-together\/\">deductible<\/a>, and out-of-pocket maximum.<\/p>\n<p>High costs of GLP-1 medications can deter insurance coverage for weight loss, and costs have influenced some insurance plans to drop coverage altogether.<\/p>\n<p>Coverage for off-label use varies by plan and indication and may be more difficult to obtain.<\/p>\n                   <\/div>\n\n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_ae518b9e12a63e5453bfb4d6f9c4e99e\">\n                            <h2 >Does Medicaid Cover GLP-1s for Diabetes and Obesity Treatment?<\/h2>                                      <p>Federal law requires <a href=\"https:\/\/www.coveragefox.com\/knowledge-center\/medicaid-loss-and-the-path-to-private-health-coverage\/\">Medicaid programs<\/a> to cover FDA-approved drugs for medically accepted indications, so Medicaid coverage for GLP-1s prescribed for diabetes is generally required nationwide.<\/p>\n<p>Coverage for weight loss or obesity is optional and varies by state. As of January 2026, <a href=\"https:\/\/www.kff.org\/medicaid\/medicaid-coverage-of-and-spending-on-glp-1s\/\" rel=\"noopener\">only 13 state Medicaid fee-for-service programs<\/a> cover GLP-1s specifically for obesity. Four states\u2014California, New Hampshire, Pennsylvania, and South Carolina\u2014have recently dropped coverage due to budget concerns. Some states, like North Carolina, have reinstated coverage.<\/p>\n<p>When covered for obesity, Medicaid programs usually require:<\/p>\n                   <\/div>\n\n\n\n<ul class=\"c-list-check\">\n                        <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Prior authorization with BMI and comorbidity documentation.<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Records of prior treatments and lifestyle efforts.<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Renewal based on demonstrated weight loss and adherence.<\/p>\n            <\/div>\n        <\/li>\n\n        \n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_5f307b9fcd8c59f79dfd1ccecb117e94\">\n                                      <p>CMS&#8217;s voluntary BALANCE Model allows participating state Medicaid agencies to expand access to select GLP-1 medications for weight management alongside lifestyle support. State participation and coverage vary.<\/p>\n<p>For Medicare, medications used only for weight loss generally are not covered under standard Part D rules. However, the Medicare GLP-1 Bridge launched July 1, 2026, and allows eligible Medicare Part D beneficiaries to access certain GLP-1 medications for weight management for a $50 monthly copay, subject to eligibility requirements and prior authorization. The program runs through December 31, 2027.<\/p>\n                   <\/div>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"720\" height=\"320\" src=\"https:\/\/www.coveragefox.com\/knowledge-center\/wp-content\/uploads\/sites\/2\/2026\/09\/are-glp-1-medications-covered-by-insurance-2.png\" alt=\"Person holding a GLP-1 injection pen, representing GLP-1 medication and insurance coverage.\" class=\"wp-image-333\" srcset=\"https:\/\/www.coveragefox.com\/knowledge-center\/wp-content\/uploads\/sites\/2\/2026\/09\/are-glp-1-medications-covered-by-insurance-2.png 720w, https:\/\/www.coveragefox.com\/knowledge-center\/wp-content\/uploads\/sites\/2\/2026\/09\/are-glp-1-medications-covered-by-insurance-2-300x133.png 300w\" sizes=\"auto, (max-width: 720px) 100vw, 720px\" \/><\/figure>\n<\/div>\n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_836eac84080ba141f83b6869e5eab4ac\">\n                            <h2 >How Have GLP-1 Coverage and Costs Changed in Recent Years?<\/h2>                                      <p>GLP-1 use has increased significantly in recent years, creating new cost and coverage considerations for insurers, employers, and government programs. Medicaid prescription volume and spending on these medications have risen sharply, while employers and private health plans continue to evaluate how and when to cover GLP-1 medications, particularly when they are prescribed for weight management.<\/p>\n<p>Because coverage can be expensive, health plans may use tools such as prior authorization, step therapy, formulary restrictions, and other utilization-management requirements. Coverage policies can also change over time as insurers, employers, and government programs evaluate costs, clinical guidelines, and patient needs.<\/p>\n<p>For consumers, this makes it especially important to review a plan&#8217;s current formulary and coverage requirements rather than assume a GLP-1 medication will be covered from one year to the next.<\/p>\n                   <\/div>\n\n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_c0fa61cf3e8cbc2832b334bc77f5f55e\">\n                            <h2 >How to Check If Your Plan Covers GLP-1 Medications<\/h2>                                      <p>Before you fill a prescription, verify what your plan will actually pay. Here&#8217;s a step-by-step approach:<\/p>\n<ol>\n<li><strong>Review the formulary:<\/strong> Search your plan&#8217;s drug list online for brand names like Ozempic, Wegovy, Mounjaro, or Zepbound. Check which tier each drug is on and whether the weight loss or diabetes indication is specified.<\/li>\n<li><strong>Call member services:<\/strong> Contact the insurance company with the exact drug name, dosage, and diagnosis code from your doctor. Ask whether the medication is covered for your specific indication-weight loss, type 2 diabetes, or cardiovascular risk reduction.<\/li>\n<li><strong>Ask about costs:<\/strong> Request your estimated monthly out-of-pocket cost after deductible, and whether any weight management program participation is required for continued coverage.<\/li>\n<li><strong>Gather documentation:<\/strong> Prepare your medical history (BMI, A1C levels, comorbidities), records of previous diet and exercise attempts, and physician notes showing medical necessity. This helps determine whether you meet your plan&#8217;s approval criteria.<\/li>\n<\/ol>\n                   <\/div>\n\n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_c4718b0225656fe2ff77b6573810bcff\">\n                            <h2 >Using the ACA Marketplace and Coverage Fox to Improve Your Chances of GLP-1 Coverage<\/h2>                                      <p>For <a href=\"https:\/\/www.coveragefox.com\/individual-health-insurance\/\">individuals<\/a> and <a href=\"https:\/\/www.coveragefox.com\/family-health-insurance\/\">families<\/a> without employer-sponsored insurance, the ACA marketplace is the primary route to private coverage that may include GLP-1 medications. But not all marketplace plans are equal when it comes to these drugs.<\/p>\n<p>How plans differ by metal tier:<\/p>\n                   <\/div>\n\n\n\n<div class=\"o-component c-simple-table js-simple-table js-expandable-content\" id=\"acf-general-simple-table-block_f75776a5b3077388833107ec64a6a9d9\">\n    <div class=\"c-simple-table__indicator js-simple-table-indicator\">\n        Scroll for more \n        <img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.coveragefox.com\/knowledge-center\/wp-content\/themes\/coveragefox\/assets\/images\/components\/simple-table\/icon-scroll.svg\" alt=\"\" aria-hidden=\"true\" width=\"30\" height=\"30\">\n    <\/div>\n    <div class=\"c-simple-table__content\">\n    <table class=\"c-simple-table__table\"><thead><tr><th>Metal Tier<\/th><th>Premiums<\/th><th>Deductibles<\/th><th>GLP-1 Coverage Likelihood<\/th><\/tr><\/thead><tbody><tr><td>Bronze<\/td><td>Lowest<\/td><td>Highest<\/td><td>Drug may be covered but you pay full price until deductible is met<\/td><\/tr><tr><td>Silver<\/td><td>Moderate<\/td><td>Moderate<\/td><td>Better formulary access; subsidies may lower costs further<\/td><\/tr><tr><td>Gold<\/td><td>Higher<\/td><td>Lower<\/td><td>Most likely to offer meaningful GLP-1 coverage with lower copays<\/td><\/tr><\/tbody><\/table>    <\/div>\n    <\/div>\n<div class=\"o-component s-cms-content\">\n    <\/div>\n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_b7ae14526230a230992a506c55f020e6\">\n                                      <p>Coverage Fox licensed agents review real plan formularies during <a href=\"https:\/\/www.coveragefox.com\/open-enrollment\/\">Open Enrollment<\/a> and <a href=\"https:\/\/www.coveragefox.com\/special-enrollment\/\">Special Enrollment<\/a> periods. They can flag which plans offer more favorable coverage for conditions like diabetes, obesity, or cardiovascular disease, and estimate total annual costs-premiums plus copays for GLP-1 users under different options.<\/p>\n<p>Subsidies and premium tax credits can offset higher premiums, making a plan with better drug coverage surprisingly affordable. Before you start treatment with a GLP-1 for weight loss or diabetes, talk with a Coverage Fox agent so you can pick coverage that aligns with your treatment journey and access to free or low-cost services where available.<\/p>\n                   <\/div>\n\n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_54812bd236fe76e308a16d1ba715ca0a\">\n                            <h2 >Appealing a GLP-1 Denial and Managing Out-of-Pocket Costs<\/h2>                                      <p>If your coverage for GLP-1s has been denied, follow these steps to appeal:<\/p>\n<ol>\n<li><strong>Read the denial letter carefully:<\/strong> It should state the exact reason-whether the plan excludes the weight loss drug category or whether your documentation was incomplete.<\/li>\n<li><strong>Work with your doctor:<\/strong> Have your prescribing clinician resubmit records including lab results, BMI history, cardiovascular risk factors, and notes on prior treatments including any reduced calorie diet or supervised exercise program.<\/li>\n<li><strong>File an internal appeal:<\/strong> If that&#8217;s denied, request an external review through your state insurance department within required deadlines.<\/li>\n<\/ol>\n                   <\/div>\n\n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_c8c58e8b9b4bdf4f7f0f326f2426d5a2\">\n                                      <p>To reduce out-of-pocket cost when coverage is limited:<\/p>\n                   <\/div>\n\n\n\n<ul class=\"c-list-check\">\n                        <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Check for manufacturer savings cards or copay assistance from drug manufacturers (these usually don&#8217;t apply to Medicaid or Medicare)<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Apply for patient assistance programs based on income<\/p>\n            <\/div>\n        <\/li>\n\n                    <li class=\"c-list-check__item\">\n            <div class=\"s-cms-content\">\n            <p>Explore alternative covered medications or lower-cost oral GLP-1 options<\/p>\n            <\/div>\n        <\/li>\n\n        \n\n        <div class=\"o-component s-cms-content \" id=\"acf-cms-content-block_6b98724c34dd9e2e7a26d8e8815631e2\">\n                                      <p>Combining any GLP-1 regimen with lifestyle changes-diet and exercise, and behavioral counseling can maximize effectiveness and potentially strengthen future coverage appeals. Coverage Fox cannot overturn a denial but can help you evaluate switching to a different health plan during the next enrollment window if your current plan carries strict GLP-1 exclusions.<\/p>\n                   <\/div>\n\n\n\n        <div class=\"c-cta-widget\">\n            <div class=\"c-cta-widget__content\">\n                                    <h2 class=\"c-cta-widget__title\">Ready to Find a Health Insurance Plan that Supports Your GLP-1 Treatment Journey?<\/h2>\n                                                    <div class=\"s-cms-content\">\n                        <p>Coverage Fox\u2019s licensed agents can help you compare health plans, identify those with better coverage for diabetes, obesity, or cardiovascular risk, and estimate your total costs. Don\u2019t navigate insurance alone. Get personalized guidance to improve your chances of coverage and manage your out-of-pocket expenses.<\/p>\n<p>Explore your options by getting a <a href=\"https:\/\/www.coveragefox.com\/plan-comparison-overview\/\">free quote<\/a> online or giving us a call at <a href=\"tel:888-676-4710\">888-676-4710<\/a> to speak with an agent today.<\/p>\n                    <\/div>\n                                <div class=\"c-form-field c-form-field__wrapper\" id=\"cta-widget\"><\/div>\n            <\/div>\n            <picture class=\"c-cta-widget__pic\">\n              <source media=\"(min-width: 43.75em)\" \n              srcset=\"https:\/\/www.coveragefox.com\/knowledge-center\/wp-content\/uploads\/sites\/2\/2026\/01\/Ima-family-lg.webp, \n              https:\/\/www.coveragefox.com\/knowledge-center\/wp-content\/uploads\/sites\/2\/2026\/01\/Ima-family-lg_2x-746x688.webp 2x\">\n              <img decoding=\"async\" class=\"c-cta-widget__img\" \n              src=\"https:\/\/www.coveragefox.com\/knowledge-center\/wp-content\/themes\/coveragefox\/assets\/images\/components\/hero\/ima-main-banner-lg.webp\" \n              srcset=\"https:\/\/www.coveragefox.com\/knowledge-center\/wp-content\/uploads\/sites\/2\/2026\/01\/Ima-family-lg.webp 2x\" \n              alt=\"\" loading=\"lazy\" width=\"280\" height=\"266\">\n            <\/picture>\n        <\/div>\n        \n\n                        <\/div>\n            <\/div>\n<\/div>\n\n\n\n    <div class=\"c-section c-section--bg-white c-section--not-top-padding\" id=\"acf-general-faqs-block_8ffe14eb571f2ba9f03da95c3f7b7b84\">\n        <div class=\" o-wrapper o-wrapper--small c-section__content\">\n        <div class=\"c-section-header\">\n            <div class=\"c-section-header__content\">\n                <h2 class=\"c-section-header__title c-section-header__title--medium c-section-header__title--centered\">FAQs<\/h2>\n            <\/div>\n        <\/div>\n        <div class=\"c-faqs\">\n                                                <details class=\"c-faqs__details\" open>\n                        <summary class=\"c-faqs__summary\">\n                            <h3 class=\"c-faqs__question\">Do health insurance plans have to cover GLP-1 drugs for weight loss?<\/h3>\n                        <\/summary>\n                        <div class=\"c-faqs__answer\">\n                            <div class=\"s-cms-content\">\n                                <p>No. As of 2026, no federal law requires private insurers, or ACA marketplace plans to cover GLP-1 medications for obesity or weight loss alone. Coverage is more common when GLP-1 medications are prescribed for type 2 diabetes or to reduce cardiovascular risk. Review each plan&#8217;s formulary and obesity drug policy before enrolling.<\/p>\n                            <\/div>\n                        <\/div>\n                    <\/details>\n                                        <details class=\"c-faqs__details\" >\n                        <summary class=\"c-faqs__summary\">\n                            <h3 class=\"c-faqs__question\">Are GLP-1 medications covered by Medicaid for everyone with obesity?<\/h3>\n                        <\/summary>\n                        <div class=\"c-faqs__answer\">\n                            <div class=\"s-cms-content\">\n                                <p>No. Medicaid coverage for GLP-1s used only for obesity varies by state and is not automatic. As of January 2026, only 13 states cover them under strict criteria, while others do not cover weight loss indications at all. Coverage for GLP-1s prescribed for diabetes is generally required. Check your state&#8217;s Medicaid policy or contact your state Medicaid office for current rules.<\/p>\n                            <\/div>\n                        <\/div>\n                    <\/details>\n                                        <details class=\"c-faqs__details\" >\n                        <summary class=\"c-faqs__summary\">\n                            <h3 class=\"c-faqs__question\">Will using a GLP-1 medication make my insurance premiums go up?<\/h3>\n                        <\/summary>\n                        <div class=\"c-faqs__answer\">\n                            <div class=\"s-cms-content\">\n                                <p>Premiums are set for large groups, not individuals. One person&#8217;s GLP-1 use won&#8217;t change their personal premium mid-year. However, at the population level, widespread GLP-1 use contributes to higher premiums over time, which is why employers and insurers closely manage utilization. When choosing a health insurance plan, look at both premium and expected GLP-1 cost sharing-a slightly higher premium plan with better coverage may save you money overall.<\/p>\n                            <\/div>\n                        <\/div>\n                    <\/details>\n                                        <details class=\"c-faqs__details\" >\n                        <summary class=\"c-faqs__summary\">\n                            <h3 class=\"c-faqs__question\">Can I switch to a new ACA marketplace plan just because my GLP-1 wasn&#8217;t covered?<\/h3>\n                        <\/summary>\n                        <div class=\"c-faqs__answer\">\n                            <div class=\"s-cms-content\">\n                                <p>Outside of Open Enrollment, you generally need a qualifying life event like losing other coverage or moving-to switch plans mid-year. A drug denial alone does not typically qualify for a Special Enrollment period. Keep records of your treatment experience and use them when comparing plans during the next enrollment window.<\/p>\n                            <\/div>\n                        <\/div>\n                    <\/details>\n                                        <details class=\"c-faqs__details\" >\n                        <summary class=\"c-faqs__summary\">\n                            <h3 class=\"c-faqs__question\">Do I still need diet and exercise if my GLP-1 is covered by insurance?<\/h3>\n                        <\/summary>\n                        <div class=\"c-faqs__answer\">\n                            <div class=\"s-cms-content\">\n                                <p>Yes. Insurers, healthcare providers, and clinical guidelines all expect GLP-1 medications to be used along with diet and exercise, not as a standalone solution. Coverage requirements vary by plan, and some policies may require participation in lifestyle or weight management programs for continued coverage. Think of GLP-1 drugs as one part of a long-term plan to support your metabolic health, not a quick fix.<\/p>\n                            <\/div>\n                        <\/div>\n                    <\/details>\n                                        <\/div>\n                \n        <\/div>\n    <\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":20,"featured_media":332,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-331","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/posts\/331","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/comments?post=331"}],"version-history":[{"count":3,"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/posts\/331\/revisions"}],"predecessor-version":[{"id":339,"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/posts\/331\/revisions\/339"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/media\/332"}],"wp:attachment":[{"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/media?parent=331"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/categories?post=331"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.coveragefox.com\/knowledge-center\/wp-json\/wp\/v2\/tags?post=331"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}